Medications | NEO (n = 175) | SUG (n = 175) | P value |
---|---|---|---|
Intraoperative period | |||
 Intravenous anesthesia, n (%) | 62 (35.4) | 56 (32) | 0.572 |
 Inhalational anesthesia, n (%) |  | ||
• Sevoflurane, n (%) | 65 (37.1) | 58 (33.1) | 0.502 |
• Desflurane, n (%) | 48 (27.4) | 61 (34.9) | 0.166 |
 Fentanyl, n (%) | 67 (38.3) | 72 (41.1) | 0.662 |
 Remifentanil, n (%) | 86 (49.1) | 92 (52.6) | 0.593 |
 Ketamine, n (%) | 20 (11.4) | 15 (8.6) | 0.476 |
 Paracetamol, n (%) | 153 (87.4) | 159 (90.9) | 0.391 |
 Morphine, n (%) | 27 (15.4) | 25 (14.3) | 0.881 |
 Tramadol, n (%) | 99 (56.6.4) | 92(52.6.3) | 0.520 |
 Vasoactive drugs, n (%) | 38 (21.7) | 35 (20) | 0.793 |
 Droperidol, n (%) | 39 (22.3.9) | 42 (24) | 0.800 |
 Ondansetron, n (%) | 149 (85.1) | 141 (80.6) | 0.321 |
 Clonidine, n (%) | 15 (8.6) | 9 (5.1) | 0.290 |
 Pethidine, n (%) | 10 (5.7) | 7 (4.0) | 0.620 |
 Cisatracurium, mg [IQR] | 36.9 [21.8-70.1] | 0.0 [0.0-0.0] | < 0.001 |
 Rocuronium, mg [IQR] | 0.0 [0.0-0.0] | 110.0 [60.0-220.0] | < 0.001 |
 Atropine (%) | 141 (80.6) | 0.0 (0.0) | < 0.001 |
 Neostigmine (%) | 175.0 (100) | 0.0 (0.0) | < 0.001 |
 Neostigmine, μg/kg | 29.9 [12.2-67.4] | 0.0 [0.0-0.0] | < 0.001 |
 Sugammadex 2 mg/kg (%) | 0 (0.0) | 101 (57.7) | < 0.001 |
 Sugammadex 4 mg/kg (%) | 0 (0.0) | 74 (42.3) | < 0.001 |
 Fluid total, ml | 2100 [1800-2500] | 2100 [1700-2400] | 0.168 |
 Surgery, min [IQR] | 185 [155-237.5] | 180 [150-225] | 0.116 |
 Anesthesia, min [IQR] | 235 [210-292.5] | 240 [205-285] | 0.589 |
Postoperative period | |||
 SpO2 at T15, % | 99 [98-99] | 99 [98-100] | 0.117 |
 HR at T15, beats/min [IQR] | 81.0 [71-91] | 82 [72.5-92.5] | 0.271 |
 SBP at T15, mmHg [IQR] | 140.0 [130-154.5] | 145 [128.5-157.5] | 0.503 |
 DBP at T15, mmHg [IQR] | 80.0 [71.0-87.5.5] | 79 [70.0-88.0] | 0.348 |
 pH at T15 [IQR] | 7.36 [7.33-7.4] | 7.36 [7.33-7.39] | 0.671 |
 PaO2 at T15, mmHg [IQR] | 88.6 [76-103.2] | 89.2 [79.5-101.4] | 0.253 |
 PaCO2 at T15, mmHg [IQR] | 39.6 [36.2-42.4] | 39.7 [36.4-43.6] | 0.207 |
 Pain NRS>3 at T15, n (%) | 18 (10.3) | 14 (8.0) | 0.579 |
 PONV NRS>3 at T15, n (%) | 13 (7.4) | 8 (4.6) | 0.368 |
 Hypoxemia, n (%) | 11 (6.3) | 1 (0.6) | 0.006 |
 Antihypertensive drugs, n (%) | 16 (9.1) | 9 (5.1) | 0.212 |
 PACU stay, min [IQR] | 90 [60-105] | 70 [60.0-90.0] | < 0.001 |
 ICU admission, n (%) | 14 [8.0] | 1 [0.6] | 0.001 |